We're using a pullback in one of our drug stocks to buy more shares

While mindful of a liability risk, we continue to believe this company's exposure will be minimal, if anything. 

from Health and Science https://ift.tt/10cqiHK
https://ift.tt/7tjzXQL
https://ift.tt/rxMJzve